Anti-Human PCSK9 Therapeutic Antibody (LPD1282/LPD1462 {i.e., antibody 1 F11))
This antibody has been
demonstrated to be a highly effective agent for lowering LDL in animal models, exhibiting up to 70% LDL reduction under the conditions tested.
demonstrated to be a highly effective agent for lowering LDL in animal models, exhibiting up to 70% LDL reduction under the conditions tested.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-0020CL |
| Pricing | Inquiry |
| Type | Humanized Antibody |
| Host | Human |
| Target | Proprotein convertase subtilisin-kexin type 9 (PCSK9) |